Revenue (Annual)

Revenue: The sum of all revenue fields included for a company's operating activities.

Phibro Animal Health Corporation (PAHC) had Revenue of $1.30B for the most recently reported fiscal year, ending 2025-06-30.

Quarterly Annual

Figures for fiscal year ending 2025-06-30

Income Statement Financials
Revenue	$1.30B
Net Income	$48.26M
Cost of Goods Sold	$896.27M
Gross Profit	$399.94M
Operating Expenses	$1.19B
Operating Income	$110.47M
Non-Operating Income/Expense	$-42.47M
Pre-Tax Income	$67.99M
Normalized Pre-Tax Income	$67.99M
Income after Taxes	$48.26M
Income from Continuous Operations	$48.26M
Consolidated Net Income/Loss	$48.26M
Normalized Income after Taxes	$48.26M
EBIT	$110.47M
EBITDA	$158.09M
Weighted-Average Shares Outstanding (Basic)	40.52M
Weighted-Average Shares Outstanding (Diluted)	40.68M
Earnings per Share (EPS) (Basic)	$1.19
Earnings per Share (EPS) (Diluted)	$1.19
Balance Sheet Financials
Current Assets	$810.61M
Property, Plant, and Equipment	$354.69M
Long-Term Assets	$550.29M
Total Assets	$1.36B
Current Liabilities	$293.47M
Long-Term Debt	$702.43M
Long-Term Liabilities	$781.75M
Total Liabilities	$1.08B
Common Equity	$285.68M
Tangible Shareholders Equity	$189.57M
Shareholders Equity	$285.68M
Common Shares Outstanding	40.53M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$80.12M
Cash Flow from Investing Activities	$-288.69M
Cash Flow from Financial Activities	$207.13M
Beginning Cash	$70.61M
End Cash	$68.04M
Increase/Decrease in Cash	$-2.57M
Stock-Based Compensation	$0.72M
Common Stock Dividends Paid	$-19.45M
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	2.76
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.71
Debt to Equity Ratio	2.52
Gross Margin	30.85%
Operating Margin	8.52%
EBIT Margin	8.52%
EBITDA Margin	12.20%
Pre-Tax Profit Margin	5.25%
Profit Margin	3.72%
Free Cash Flow	$41.83M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.95
Inventory Turnover	2.02
Receiveable Turnover	5.69
Days Sales in Receivables	64.20
Return on Equity	16.89%
Return on Tangible Equity	25.46%
Return on Assets	3.55%
Return on Investments	4.88%
Book Value Per Share	$7.05
Free Cash Flow per Share	$1.03
Operating Cash Flow per Share	$1.97

Data from Zacks Investment Research, Inc.